College of Science and Engineering, Hamad Bin Khalifa University, Doha, Qatar.
Department of Computer Science & Engineering, Bangladesh University of Engineering and Technology, Dhaka, Bangladesh.
Stud Health Technol Inform. 2022 Jan 14;289:9-13. doi: 10.3233/SHTI210846.
Tremendous changes have been witnessed in the post-COVID-19 world. Global efforts were initiated to reach a successful treatment for this emerging disease. These efforts have focused on developing vaccinations and/or finding therapeutic agents that can be used to combat the virus or reduce its accompanying symptoms. Gulf Cooperation Council (GCC) countries have initiated efforts on many clinical trials to address the efficacy and the safety of several therapeutic agents used for COVID-19 treatment. In this article, we provide an overview of the GCC's clinical trials and associated drugs' discovery process in the pursuit of an effective medication for COVID-19.
在后 COVID-19 时代,世界发生了巨大的变化。全球各国都在努力寻找治疗这种新兴疾病的有效方法。这些努力主要集中在开发疫苗和/或寻找治疗药物,以对抗病毒或减轻其伴随症状。海湾合作委员会(GCC)国家已经启动了多项临床试验,以评估几种用于 COVID-19 治疗的治疗药物的疗效和安全性。本文概述了 GCC 国家为寻找 COVID-19 有效药物而进行的临床试验和相关药物发现过程。